The latest announcement: There are more than 560,000 pharmacies nationwide

According to the latest news from the National Food and Drug Administration, as of the end of March 2021, the number of pharmacies nationwide has exceeded 560,000

In 3 months, 7,100 more pharmacies nationwide

On June 28, the State Food and Drug Administration announced the first quarter of 2021 drug supervision and management statistical report (hereinafter referred to as the "report")

The report shows that as of the end of March 2021, there are 580,800 companies that hold the Pharmaceutical Business License across the country

Compared with the data at the end of 2020, there are 295 more retail chain headquarters, 6,200 more retail chain stores, and 900 more single drug stores

(Picture: Cyber ​​Blue—produced by the pharmacy manager)

The approval of pharmacies was liberalized in many places, and the chain rate was further increased

As of the end of March 2021, the chain rate of retail pharmacies in China was 56.

It should be noted that the improvement of domestic retail pharmacy chains is closely related to policies

The State Council’s "National Deepening of "Decentralization, Management and Service" Reform and Optimization of the Business Environment Video and Telephone Conference Key Task Division Plan" clearly stated that the approval of pharmacies should be optimized, and the approval of retail companies that only deal in Category B non-prescription drugs should be implemented nationwide.

At present, Zhejiang, Heilongjiang, Shanghai, Jiangsu, Fujian and other provinces and cities have begun to implement it.

In addition, Shandong, Shaanxi, Shanghai, Jiangsu and other places have also begun to pilot the reform of "one industry, one license" for retail pharmacies, combining multiple licenses for a retail pharmacy into one comprehensive industry license that contains relevant administrative licensing information

Take Shanghai as an example.

Supervision is getting stricter and 561,200 pharmacies have been inspected in 3 months

According to the State Council’s “decentralization and service” requirements, on the one hand, the approval of retail pharmacies should be greatly liberalized, and on the other hand, the supervision during and after the event should be strengthened simultaneously

The report pointed out that during the reporting period, the provincial and sub-provincial regulatory agencies inspected 5,159 pharmaceutical wholesale companies, found 701 companies that violated the relevant management regulations on drug business, and completed 610 rectifications

Provincial and sub-provincial regulatory agencies inspected a total of 561,200 pharmaceutical retail companies, found 17,300 companies that violated the relevant regulations on drug business management, and completed 17,900 rectifications

In addition, according to the report, the author also sorted out the situation of pharmaceutical manufacturers, medical device manufacturers, and operating companies

Licensing status of pharmaceutical manufacturing enterprises: As of the end of March 2021, there are a total of 7,083 "Drug Production Licenses" (including Chinese medicine decoction pieces, medical gases, etc.

Daily supervision of pharmaceutical manufacturing enterprises: During the reporting period, the provincial and sub-provincial regulatory agencies inspected 3166 pharmaceutical manufacturing enterprises, found 17 illegal production enterprises, discovered 304 illegal production enterprises, and completed 477 rectifications

Basic information of medical device manufacturers: As of the end of March 2021, there are 26,800 medical device manufacturers nationwide, including: 15,500 companies that can produce type 1 products1, and 13,300 companies that can produce type 2 products , There are 2097 companies that can produce the third category of products
.

Daily supervision of medical device production: During the reporting period, the provincial and sub-provincial regulatory agencies inspected 5602 medical device manufacturers, comprehensively inspected 1,327 sterile medical device manufacturers of high-risk enterprises, and comprehensively inspected the implantability of high-risk enterprises.
There were 139 medical device manufacturers, and 573 medical device manufacturers in the third category of high-risk enterprises were comprehensively inspected
.

Basic situation of medical device operating companies: As of the end of March 2021, there are actually 939,900 second and third types of medical device operating companies across the country, of which 623,900 are only operating in the second category of medical device products, and only operating in the third category.
There are 76,600 medical device products companies, and 239,400 companies engaged in the second and third categories of medical device operations at the same time
.
There are 776 companies that provide third-party platform services for medical device online transaction services
.

Daily supervision of the operation and use of medical devices: During the reporting period, the provincial and sub-provincial regulatory agencies inspected 389,900 medical device operating companies and users, found 9,098 companies or units that violated laws and regulations, and completed 10,200 rectifications.
Home times
.

As of the end of March 2021, the status of pharmaceutical business enterprises in all provinces (autonomous regions and municipalities):

As of the end of March 2021, the status of pharmaceutical manufacturers in each province (autonomous region, municipality):

As of the end of March 2021, the status of medical device operating companies in all provinces (autonomous regions and municipalities):

As of the end of March 2021, the status of medical device manufacturers in various provinces (autonomous regions and municipalities):